Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Valentina Favoni
Sign up to set email alerts
116
Publications
1,636
Citation Statements Received
4,059
Citation Statements Given
How they've been cited
1,918
110
1,507
19
How they cite others
3,287
161
3,874
24
Affiliations
Istituto delle Scienze Neurologiche di Bologna
,
University of Bologna
Publications
Order By: Most citations
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Vernieri
1
,
Altamura
2
,
Brunelli
3
et al.
2021
J Headache Pain
Abstract
Show
160
23
153
2
Get access via publisher
Add to collection
Cite
SUNCT/SUNA and neurovascular compression: New cases and critical literature review
Favoni
1
,
Grimaldi
2
,
Pierangeli
3
et al.
2013
Cephalalgia
Abstract
Show
88
11
98
2
Get access via publisher
Add to collection
Cite
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
Vernieri
1
,
Altamura
2
,
Brunelli
3
et al.
2021
Euro J of Neurology
Abstract
Show
79
11
97
4
1
Get access via publisher
Add to collection
Cite
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Favoni
1
,
Giani
2
,
Al‐Hassany
3
et al.
2019
J Headache Pain
Abstract
Show
147
2
86
1
Get access via publisher
Add to collection
Cite
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
Pensato
1
,
Baraldi
2
,
Favoni
3
et al.
2021
Neurol Sci
61
7
70
4
Get access via publisher
Add to collection
Cite
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
Vernieri
1
,
Brunelli
2
,
Messina
3
et al.
2021
J Headache Pain
Abstract
Show
77
10
60
0
Get access via publisher
Add to collection
Cite
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network
Lupi
1
,
Evangelista
2
,
Favoni
3
et al.
2018
Cephalalgia
Abstract
Show
25
0
77
0
Get access via publisher
Add to collection
Cite
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
Pensato
1
,
Baraldi
2
,
Favoni
3
et al.
2022
Cephalalgia
Abstract
Show
45
0
65
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5